Sok, Davin and Clarizia, LJ and Farris, L and McDonald, MJ. (2009) Novel fluoroimmunoassay for ovarian cancer biomarker CA-125. Analytical and Bioanalytical Chemistry, 393 (5). p. 1521. ISSN 16182642
Full text not available from this repository. (Request a copy)Abstract
Cancer antigen 125 (CA-125) is a glycoprotein biomarker that denotes the presence of ovarian and reproductive cancers in women, with serum concentrations of CA-125 greater than 35 U/ml considered indicative of potential malignancies. A fluorescent immunoassay recently developed in our laboratory employing the ALYGNSA antibody-orientation system has been used to measure CA-125 levels. This system displayed significantly increased sensitivity with a detection limit of 1.5 U/ml compared to that of a commercial CA-125 enzyme-linked immunosorbent assay (15 U/ml) This tenfold lower level of detection of the ALYGNSA CA-125 assay should permit better identification and monitoring of ovarian cancer.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Fluoroimmunoassay; ELISA; Cancer biomarker; CA-125 |
| InterNano Taxonomy: | Environment, Health, and Safety > Human Health |
| Collections: | Nanomanufacturing Research Collection > Nanomanufacturing Nanoscale Science and Engineering Centers > Center for High-rate Nanomanufacturing Nanomanufacturing Research Collection |
| Depositing User: | Danielle Federa |
| Date Deposited: | 16 Jun 2009 17:25 |
| Last Modified: | 19 Sep 2011 20:49 |
| URI: | http://eprints.internano.org/id/eprint/100 |
Actions (login required)
 |
View Item |
